Showing results (121-130 of 146) with videos related to
Sort By:
Pageof 15
Anti-Cancer Drug Design|October 1, 1994
Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugatesJ P Gesson, J C Jacquesy, M Mondon, et al.Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.Chemical & Pharmaceutical Bulletin|March 3, 2004
Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamatesHuong Doan Thi Mai, Thomas Gaslonde, Sylvie Michel, et al.Molecular Pharmacology|November 28, 2001
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosisS Léonce, V Pérez, S Lambel, et al.Chinese Journal of Integrative Medicine|August 11, 2010
Antimicrobial activity of the methanolic extract and compounds from the stem bark of Drypetes tessmannianaVictor Kuete, Marlise D J Dongfack, Armelle T Mbaveng, et al.Chemical & Pharmaceutical Bulletin|August 5, 2005
Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine seriesHuong Doan Thi Mai, Thomas Gaslonde, Sylvie Michel, et al.Phytochemistry|October 3, 2000
Sesquiterpene lactone and friedelane derivative from drypetes molunduanaJ Wandji, J D Wansi, V Fuendjiep, et al.Journal of Ethnopharmacology|June 9, 2009
Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell linesMariana Laundry de Mesquita, José Elias de Paula, Cláudia Pessoa, et al.Journal of Medicinal Chemistry|July 6, 2000
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycineN Costes, H Le Deit, S Michel, et al.Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.Pageof 15